Primary Care and Infectious Disease Provider Adherence to HIV Pre-exposure Prophylaxis (PrEP) Prescribing and Monitoring Recommendations-Reference-Cited by-同舟云学术

Primary Care and Infectious Disease Provider Adherence to HIV Pre-exposure Prophylaxis (PrEP) Prescribing and Monitoring Recommendations

Published:2023-08-05 Issue: Volume: Page:
ISSN:1090-7165
Container-title:AIDS and Behavior
language:en
Short-container-title:AIDS Behav

Author:

Tandon Anushka,Saseen Joseph J.^ORCID,Fink Rhianna M.^ORCID,Billups Sarah J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology

Link

https://link.springer.com/content/pdf/10.1007/s10461-023-04154-5.pdf

Reference15 articles.

1. Effectiveness of Prevention Strategies to Reduce the Risk of Acquiring or Transmitting HIV. In: Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/hiv/risk/estimates/preventionstrategies.html#anchor_1562942347. Accessed 21 Mar 2023.

2. PrEP for HIV prevention in the U.S. 2021. In: Centers for Disease Control and Prevention. https://www.cdc.gov/nchhstp/newsroom/fact-sheets/hiv/PrEP-for-hiv-prevention-in-the-US-factsheet.html. Accessed 21 Mar 2023.

3. Schackman BR, Fleishman JA, Su AE, et al. The lifetime medical cost savings from preventing HIV in the United States. Med Care. 2015;53(4):293–301. https://doi.org/10.1097/mlr.0000000000000308.

4. Zhu W, Huang YA, Kourtis AP, Hoover KW. Trends in the number and characteristics of HIV pre-exposure prophylaxis providers in the United States, 2014–2019. J Acquir Immune Defic Syndr. 2021;88(3):282–89. https://doi.org/10.1097/qai.0000000000002774.

5. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update: Clinical Providers’ Supplement. In: Centers for Disease Control and Prevention. 2018. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-provider-supplement-2017.pdf. Accessed 21 Mar 2023.